TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - ABBOTT LABORATORIES Share Price

Certificat

DE000SQ2CNZ1

Delayed Deutsche Boerse AG 02:32:54 06/06/2024 pm IST
2.01 EUR -2.90% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - ABBOTT LABORATORIES
Current month+7.81%
1 month-14.11%
Date Price Change
06/24/06 2.01 -2.90%
05/24/05 2.07 -0.48%
04/24/04 2.08 +1.96%
03/24/03 2.04 +6.25%
31/24/31 1.92 -1.54%

Delayed Quote Deutsche Boerse AG

Last update June 06, 2024 at 02:32 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
WKN SQ2CNZ
ISINDE000SQ2CNZ1
Date issued 29/09/2022
Strike 80.92 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.86
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.99
Lowest since issue 1.3
Spread 0.08
Spread %3.83%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103.2 USD
Average target price
125.4 USD
Spread / Average Target
+21.45%
Consensus